Abstract:
Methods of making engineered multivalent and multi-specific binding proteins, and using the binding proteins in the prevention, diagnosis, and/or treatment of disease are provided. The multivalent binding proteins may contain more than one linked heavy chain and/or light chain variable regions joined by a constant region to an Fc region. The multivalent binding proteins may bind to a number of cytokines, hormones, growth factors, small molecules or cell surface receptors, including NGF and any of a number of small molecules, growth factors, cytokines, hormones or cell surface receptors.
Abstract:
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention and/or treatment of acute and chronic inflammatory and other diseases.
Abstract:
The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind to the Nogo-66 receptor. Specifically, these antibodies have the ability to inhibit the binding of the natural ligand of the Nogo-66 receptor and neutralize the Nogo-66 receptor. These antibodies or portions thereof of the invention are useful for detecting NgR and for inhibiting NgR activity, for example in a human suffering from a disorder in which NgR or Nogo-66 activity is detrimental.
Abstract:
Engineered multivalent and multispecific binding proteins, methods of making, and their uses in the prevention, diagnosis, and/or treatment of disease are provided.
Abstract:
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
Abstract:
The invention provides compositions, methods, and kits related to half-Ig binding proteins that include a functional antibody binding site and a CH3 domain wherein the CH3 domain includes at least one mutation to inhibit CH3-CH3 dimerization.
Abstract:
Engineered multivalent and multispecific binding proteins, methods of making, and their uses in the prevention, diagnosis, and/or treatment of disease are provided.
Abstract:
Proteins that bind IL-1a and IL-1ß are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1 -related disorders and for detecting IL-1a and IL-1ß in cells, tissues, samples, and compositions.
Abstract:
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.